γδ T Cells in Cancer
Publisher
Springer New York
Reference142 articles.
1. Allison JP, Havran WL (1991) The immunobiology of T cells with invariant gamma delta antigen receptors. Annu Rev Immunol 9:679–705
2. Argentati K, Re F et al (2003) Reduced number and impaired function of circulating gamma delta T cells in patients with cutaneous primary melanoma. J Invest Dermatol 120(5):829–834
3. Bauer S, Groh V et al (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA [see comments]. Science 285(5428):727–729
4. Bennouna J, Bompas E et al (2008) Phase-I study of Innacell gammadeltatrade mark, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother 57(11):1599–1609
5. Bennouna J, Levy V et al (2010) Phase-I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors. Cancer Immunol Immunother 59(10):1521–1530. Epub 2010 Jun 19